12 March 2021 1 Min Read
Human trials begin of Sanofi and Translate Bio’s Covid-19 vaccine candidate
It is the latest vaccine candidate based on messenger RNA, after jabs by Pfizer-BioNTech and Moderna were launched when clinical trials showed high efficacy rates
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In